Académique Documents
Professionnel Documents
Culture Documents
6%
EBITDA at ` 42.3 Mn, Margin of 25.6%
PAT at ` 14.6 Mn, up by 114%
August 12, 2015, Delhi: Sunil Healthcare Ltd, a leading manufacturer of Empty Hard Gelatin
Capsules, has announced its Un-audited Financial Results for the quarter ended 30th June
2015.
Key Financial Highlights :
` Million
Q1FY16
Q1FY15
YoY%
Revenue
165.7
154.0
7.6%
EBITDA
42.3
29.8
41.9%
EBITDA Margin
25.6%
19.4%
620 bps
24.8
11.8
111.0%
PAT
14.6
68.0
113.9%
PAT Margin
8.8%
4.4%
440 bps
Cash PAT
23.6
19.3
21.9%
14.2%
12.5%
170 bps
Performance Highlights:
Revenues for the quarter stood at ` 165.7 mn, recording a 7.6% growth YoY. EBIDTA for the
quarter was at ` 42.3 mn, and EBITDA margins stood at 25.6%, an expansion of 620 bps YoY.
Net Profit After Tax was at ` 14.6 mn, growth of 113.9% over Q1 FY15. PAT margin was at
8.8%, an expansion of 440 bps YoY. Cash PAT margin came in at 14.2% an improvement of
170 bps YoY.
Commenting on the results, Mr. D. Gnanasekaran (CEO) said We are happy to report strong
quarterly performance, which sees a growth of 7.6 % in our top line, and 41.9 % in EBITDA.
Our rigorous focus on delivering on key customers matrix has enabled us to build on new
customers in domestic and international markets, bringing new geographies under our
umbrella.